Why One Technical Analyst Warns The Market Is Headed For A Near-Term Pullback

The market could be in for some pain ahead. Here’s why.

The three major indexes may have just notched fresh record highs, but according to one expert technical analyst, we could be in for some pain ahead.

JC O’Hara, chief market technician at MKM Partners, told CNBC that the stocks market is “a little overbought in the short term,” and now the question is whether it’s “a good overbought or a bad overbought.”

To answer this, O’Hara examined how much time the S&P 500 has spent above its short-term, 10-day moving average.

Source: CNBC.

“We found the streak to be 30 days,” O’Hara said, adding that while that streak ended late last week, it’s still “one of the longest streaks on record.”

Over the last decade, the S&P has seen five similar streaks.

“What we found was the market had a very minor pullback, consolidated for a few weeks before ultimately, in most cases, resuming its uptrend,” the technical analyst said. “So, I don’t want to get too negative here. Yes, we’re up a bunch, but I think if we repeat history here, we’re due for a short-term consolidation before resumption of the uptrend.”

O’Hara isn’t alone in anticipating pain in the near-term. 

RBC chief U.S. equity strategist Lori Calvasina warns that a pullback is on the horizon on the basis that many of the biggest money managers are more positive on stocks than they have been in months.

“This keeps us on guard for a period of significant consolidation near-term, and will be an overhang on 2020 performance if not resolved before year end,” Calvasina wrote in a note.

“We expect 2020 to be a year of moderation, turbulence, and transition in the U.S. equity market,” Calvasina continued. “Risk of a pullback near-term is quite high in our opinion. If a pullback doesn’t occur by the end of 2019, as we’ve anticipated, then we suspect it will come in 1Q20.”

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More